Chronic gastritis is a long-lasting inflammation of the stomach lining that can lead to complications like ulcers or an increased risk of stomach cancer. Common causes include H. pylori infection or autoimmune disorders. Patients may need ongoing treatment with medications to reduce stomach acid and eradicate infections.

Ozempic is a prescription medication used primarily to treat type 2 diabetes but has recently gained attention for its off-label use in promoting weight loss. Ozempic contains semaglutide, which helps regulate blood sugar and appetite, making it an effective treatment for individuals struggling with obesity. Weight loss clinics may prescribe Ozempic as part of a broader weight management program.

Answer: Mini Gastric Bypass patients generally lose a lot of weight very quickly. The average amount of weight loss after three months is one third of the patient's excess weight. Patients can lose up to 75%-85% of their excess weight within 1 year.

Weight loss before surgery was associated with readmission for abdominal pain and increases in urinary tract and surgical site infections, researchers found. The tradition may also be tied to insurance carriers who require weight loss and counseling before surgical treatment.

The Orbera gastric balloon is a non-surgical, temporary weight-loss device placed in the stomach to reduce food intake. The balloon is inflated and left in place for six months. During that time, patients follow a strict diet and exercise regimen to lose weight. It’s a popular choice for patients who want to avoid invasive surgery.